MacroGenics Inc
NASDAQ:MGNX

Watchlist Manager
MacroGenics Inc Logo
MacroGenics Inc
NASDAQ:MGNX
Watchlist
Price: 1.37 USD -0.72% Market Closed
Market Cap: 86.7m USD

Wall Street
Price Targets

MGNX Price Targets Summary
MacroGenics Inc

Wall Street analysts forecast MGNX stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for MGNX is 3.47 USD with a low forecast of 2.02 USD and a high forecast of 5.25 USD.

Lowest
Price Target
2.02 USD
47% Upside
Average
Price Target
3.47 USD
153% Upside
Highest
Price Target
5.25 USD
283% Upside
MacroGenics Inc Competitors:
Price Targets
FOLD
Amicus Therapeutics Inc
70% Upside
NIOX
Niox Group PLC
19% Upside
FHTX
Foghorn Therapeutics Inc.
174% Upside
TIL
Instil Bio Inc
794% Upside
JSPR
Jasper Therapeutics Inc
665% Upside
BCRX
BioCryst Pharmaceuticals Inc
177% Upside
CRBU
Caribou Biosciences Inc
497% Upside
196170
Alteogen Inc
18% Upside

Revenue
Forecast

Revenue Estimate
MacroGenics Inc

For the last 12 years the compound annual growth rate for MacroGenics Inc's revenue is 7%. The projected CAGR for the next 3 years is -25%.

7%
Past Growth
-25%
Estimated Growth
Estimates Accuracy
-4%
Average Miss

Operating Income
Forecast

Operating Income Estimate
MacroGenics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
2%
Average Beat

Net Income
Forecast

Net Income Estimate
MacroGenics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-37%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is MGNX's stock price target?
Price Target
3.47 USD

According to Wall Street analysts, the average 1-year price target for MGNX is 3.47 USD with a low forecast of 2.02 USD and a high forecast of 5.25 USD.

What is MacroGenics Inc's Revenue forecast?
Projected CAGR
-25%

For the last 12 years the compound annual growth rate for MacroGenics Inc's revenue is 7%. The projected CAGR for the next 3 years is -25%.

Back to Top